Secondary Myelofibrosis Recruiting Phase 1 Trials for Mechlorethamine (DB00888)

IndicationStatusPhase
DBCOND0030964 (Secondary Myelofibrosis)Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03118492Combination Chemotherapy, Total Body Irradiation, and Donor Blood Stem Cell Transplant in Treating Patients With Secondary MyelofibrosisTreatment